Jill Barrella, United States says,
"Seemed easy to purchase, reasonable prices. Good customer service when I used it."

Brian Pavey, United States says,
"I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."

Eric Gonzales, United States says,
"The website is very user friendly, there is a lot of variety and checking out was easy."

Albert Martinez, United States says,
"Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."

Natalie Wallace, United States says,
"I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."

'Indian pharma brand building campaign' to be held in SA

Posted AtPharmabiz.com

To counter the multinational companies' (MNCs) propaganda against the Indian generic drugs in the African countries, the Indian government will conduct an 'Indian pharma brand building campaign' in South Africa on July 22. A high level delegation of Union commerce ministry, including major exporters and members from Confederation Indian Industry (CII), will participate in the campaign.

The brand building programme will be part of the Indian government's aggressive campaign against the MNCs' propaganda against generic drugs in the African countries. The brand building programme will be a major platform for the Indian pharma industry and the government to allay any fears among the African countries about the quality of Indian generic drugs. Drug Controller General of India (DCGI) Dr Surinder Singh is also expected to be part of the delegation.

Main objective of the Indian government's aggressive campaign in the African countries is to desist these countries from introducing laws in their countries under which the generic drugs will be treated as counterfeit drugs. Under the influence of the MNCs propaganda, some African countries like Kenya and Uganda had recently come out with draft Bills under which even generic drugs will be classified as counterfeit drugs. India is concerned over the development because of the fact that apart from Kenya and Uganda, other African countries are also intending to follow suit which will put the Indian pharma industry in great trouble as Indian companies are the major exporters of generic drugs to several African countries.

The 'Indian pharma brand building campaign' will have to convince the African countries about the quality of Indian generic drugs and also to convince them that generic drugs are not counterfeit drugs as is being spread by the MNCs. The MNCs are learnt to be spreading the rumours in the African countries that the Indian generic drugs are spurious drugs and only patented drugs, manufactured mostly by the MNCs, are good for consumption.

Concerned over the MNCs' propaganda against the Indian generic drugs in African countries, the Union commerce ministry had initiated some proactive actions to counter them in the recent past. On April 24 this year, the ministry had called a meeting of all the Ambassadors and High Commissioners of African countries in India to clarify and convince the African countries how the generic drugs are being manufactured in India after complying with strict quality parameters. The meeting discussed the status of Indian pharma and issues related to improvement in bilateral trade between India and African countries.

Trademark names that appear on this site are the property of each trademark holder.
We do not claim any affiliation with or to in any way connected to any manufacturer of offered products nor do we claim to be affiliated with or in any way connected to any holders of trademarks. Read more...